Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: Analysis of three randomized controlled trials

European Journal of Heart Failure

Volumn 13, Issue 11, 2011, Pages 1224-1230

  Testani, Jeffrey M ^a   Coca, Steven G ^b   Shannon, Richard P ^a   Kimmel, Stephen E ^a   Cappola, Thomas P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardio renal syndrome; Chronic kidney disease; Heart Failure; Mortality; Neurohormonal activation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LOOP DIURETIC AGENT; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROPENSITY SCORE; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 80155153008     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr123     Document Type: Article

References (27)

1. Bock JS, Gottlieb SS. Cardiorenal syndrome: New perspectives. Circulation 2010; 121:2592-2600.
2. Hebert K, Dias A, Delgado MC, Franco E, Tamariz L, Steen D, Trahan P, Major B, Arcement LM. Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population. Eur J Heart Fail 2010;12:861-865.
3. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol 2009;53: 557-573.
4. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
5. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210.
6. Lindenfeld J, Schrier RW. Blood urea nitrogen a marker for adverse effects of loop diuretics? J Am Coll Cardiol 2011;58:383-385.
7. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-621.
8. Kazory A. Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 2010;106:694-700.
9. Schrier RW. Blood urea nitrogen and serum creatinine: Not married in heart failure. Circ Heart Fail 2008;1:2-5.
10. Macedo E, Mehta R. Prerenal azotemia in congestive heart failure. Contrib Nephrol 2010;164:79-87.
11. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
12. The SOLVD Investigattors. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
13. Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001;344: 1659-1667.
14. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW, Investigators E, Coordinators ES. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 2005;294:1625-1633.
15. Shah MR, O'Connor CM, Sopko G, Hasselblad V, Califf RM, Stevenson LW. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationale. Am Heart J 2001;141:528-535.
16. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology C. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Internal Med 2006;145:247-254.
17. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125-137.
18. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-689.
19. Brenner BM, Rector FC. Brenner & Rector's the Kidney. Philadelphia: Saunders Elsevier; 2008.
20. Fenton RA. Essential role of vasopressin-regulated urea transport processes in the mammalian kidney. Pflugers Arch, Eur J Physiol 2009;458:169-177.
21. Kato A, Klein JD, Zhang C, Sands JM. Angiotensin II increases vasopressinstimulated facilitated urea permeability in rat terminal IMCDs. Am J Physiol, Renal Physiol 2000;279:F835-F840.
22. Cecil RL, Goldman L, Ausiello DA. Cecil Medicine. 23rd ed. Philadelphia: Saunders Elsevier; 2008.
23. Blair JE, Manuchehry A, Chana A, Rossi J, Schrier RW, Burnett JC, Gheorghiade M. Prognostic markers in heart failure-congestion, neurohormones, and the cardiorenal syndrome. Acute Card Care 2007;9:207-213.
24. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-305.
25. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-15.
26. Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010;363:1419-1428.
27. Vallon V, Miracle C, Thomson S. Adenosine and kidney function: Potential implications in patients with heart failure. Eur J Heart Fail 2008;10:176-187.